IDYA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,168,290.29

IDEAYA Biosciences Insider Trading History Chart

IDEAYA Biosciences Share Price & Price History

^$25.61

▲ +0.82 (3.31%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

⭕ [URGENT] Buy Alert just triggered

From Behind the Markets | Ad

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

IDEAYA Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2024	Michael Anthony White	insider	Sell	28,500	$36.24	$1,032,840.00
5/16/2024	Yujiro S. Hata	CEO	Sell	34,433	$41.81	$1,439,643.73	677,887
5/14/2024	Yujiro S. Hata	CEO	Sell	56,711	$41.61	$2,359,744.71	677,887
2/9/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$46.02	$92,040.00	24,531
2/9/2024	Yujiro S. Hata	CEO	Sell	23,557	$45.54	$1,072,785.78	677,887
1/22/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$42.03	$84,060.00	26,531
1/16/2024	Yujiro S. Hata	CEO	Sell	62,739	$40.17	$2,520,225.63	677,887
1/12/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$38.01	$76,020.00	28,531
1/12/2024	Yujiro S. Hata	CEO	Sell	12,261	$40.04	$490,930.44	677,887
12/15/2023	Yujiro S. Hata	CEO	Sell	75,000	$35.03	$2,627,250.00	677,887
12/14/2023	Andres Ruiz Briseno	Insider	Sell	2,000	$34.00	$68,000.00	30,531
11/3/2023	Jason Throne	insider	Sell	5,163	$30.09	$155,354.67
9/12/2023	Jason Throne	insider	Sell	1,000	$30.00	$30,000.00
9/5/2023	Jason Throne	insider	Sell	1,737	$30.03	$52,162.11
9/1/2023	Jason Throne	insider	Sell	2,100	$30.03	$63,063.00	32,531
8/29/2023	Paul A. Stone	CFO	Sell	5,000	$28.87	$144,350.00	9,303
8/21/2023	Paul A. Stone	CFO	Sell	978	$26.40	$25,819.20	14,303
8/18/2023	Paul A. Stone	CFO	Sell	3,822	$26.38	$100,824.36	15,281
8/16/2023	Paul A. Stone	CFO	Sell	200	$26.43	$5,286.00	19,103
8/9/2023	Jason Throne	insider	Sell	5,000	$25.09	$125,450.00
8/9/2023	Paul A. Stone	CFO	Sell	2,500	$25.05	$62,625.00	19,303
7/10/2023	Jason Throne	insider	Sell	9,485	$23.00	$218,155.00
5/31/2023	Jason Throne	insider	Sell	432	$23.00	$9,936.00
5/22/2023	Jason Throne	insider	Sell	500	$23.00	$11,500.00

Vladimir Lenin was right…

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for IDEAYA Biosciences (NASDAQ:IDYA)

98.29% of IDEAYA Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IDEAYA Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	7,720	$0.25M	0.0%	-39.2%	0.009%
11/16/2024	Geode Capital Management LLC	1,945,455	$61.65M	0.0%	+9.8%	2.251%
11/15/2024	Barclays PLC	181,170	$5.74M	0.0%	+188.8%	0.210%
11/15/2024	Orion Portfolio Solutions LLC	29,553	$0.94M	0.0%	-15.8%	0.034%
11/15/2024	XTX Topco Ltd	7,719	$0.25M	0.0%	N/A	0.009%
11/15/2024	Jane Street Group LLC	79,537	$2.52M	0.0%	-38.3%	0.092%
11/15/2024	Wellington Management Group LLP	42,111	$1.33M	0.0%	-77.6%	0.049%
11/15/2024	Two Sigma Advisers LP	468,100	$14.83M	0.0%	+1.7%	0.542%
11/15/2024	State Street Corp	3,317,936	$105.11M	0.0%	+15.4%	3.839%
11/15/2024	Stifel Financial Corp	27,536	$0.87M	0.0%	-6.4%	0.032%
11/15/2024	RA Capital Management L.P.	1,347,252	$42.68M	0.5%	N/A	1.559%
11/15/2024	Readystate Asset Management LP	16,423	$0.52M	0.0%	N/A	0.019%
11/15/2024	RTW Investments LP	200,000	$6.34M	0.1%	N/A	0.231%
11/15/2024	Redmile Group LLC	681,150	$21.58M	1.3%	-10.3%	0.788%
11/15/2024	Janus Henderson Group PLC	5,162,376	$163.52M	0.1%	+26.7%	5.973%
11/15/2024	Holocene Advisors LP	562,848	$17.83M	0.1%	-69.9%	0.651%
11/15/2024	Paloma Partners Management Co	6,708	$0.21M	0.0%	N/A	0.008%
11/14/2024	Bellevue Group AG	7,200	$0.23M	0.0%	+26.3%	0.008%
11/14/2024	Verition Fund Management LLC	7,771	$0.25M	0.0%	N/A	0.009%
11/14/2024	Sio Capital Management LLC	123,000	$3.90M	1.5%	N/A	0.142%
11/14/2024	Walleye Capital LLC	141,171	$4.47M	0.0%	+955.8%	0.163%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	318,496	$10.09M	0.0%	+2.0%	0.369%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	20,768	$0.66M	0.0%	+26.3%	0.024%
11/14/2024	MetLife Investment Management LLC	47,358	$1.50M	0.0%	+9.6%	0.055%
11/13/2024	BNP Paribas Financial Markets	28,149	$0.89M	0.0%	-62.2%	0.033%
11/13/2024	Quantbot Technologies LP	2,627	$83K	0.0%	N/A	0.003%
11/13/2024	FMR LLC	12,635,653	$400.30M	0.0%	+12.1%	14.620%
11/13/2024	The Manufacturers Life Insurance Company	98,387	$3.12M	0.0%	-6.1%	0.114%
11/13/2024	Fisher Asset Management LLC	848,909	$26.89M	0.0%	+26.7%	0.982%
11/12/2024	Charles Schwab Investment Management Inc.	689,073	$21.83M	0.0%	+12.9%	0.797%
11/9/2024	Intech Investment Management LLC	28,920	$0.92M	0.0%	N/A	0.033%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	50,370	$1.60M	0.0%	-38.1%	0.060%
11/8/2024	Jennison Associates LLC	972,266	$30.80M	0.0%	+136.6%	1.151%
11/7/2024	Quest Partners LLC	34,062	$1.08M	0.1%	+2,791.5%	0.040%
11/6/2024	KBC Group NV	2,274	$72K	0.0%	+29.1%	0.003%
11/5/2024	Victory Capital Management Inc.	313,257	$9.92M	0.0%	-0.9%	0.371%
11/5/2024	GSA Capital Partners LLP	15,063	$0.48M	0.0%	N/A	0.018%
11/5/2024	Entropy Technologies LP	8,674	$0.28M	0.0%	N/A	0.010%
11/4/2024	State of New Jersey Common Pension Fund D	49,839	$1.58M	0.0%	-3.8%	0.059%
11/2/2024	Covestor Ltd	926	$29K	0.0%	+23,050.0%	0.001%
11/1/2024	Assetmark Inc.	44,185	$1.40M	0.0%	+11.3%	0.052%
11/1/2024	Fiera Capital Corp	1,289,820	$40.86M	0.1%	-3.4%	1.527%
10/31/2024	General American Investors Co. Inc.	90,000	$2.85M	0.2%	N/A	0.119%
10/31/2024	Principal Financial Group Inc.	7,720	$0.25M	0.0%	-39.2%	0.010%
10/30/2024	Amalgamated Bank	2,840	$90K	0.0%	+22.9%	0.004%
10/28/2024	US Bancorp DE	1,714	$54K	0.0%	+67.2%	0.002%
10/28/2024	Palumbo Wealth Management LLC	7,047	$0.22M	0.1%	N/A	0.008%
10/25/2024	China Universal Asset Management Co. Ltd.	16,249	$0.52M	0.1%	+82.7%	0.021%
10/25/2024	abrdn plc	232,830	$7.38M	0.0%	N/A	0.308%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,056	$94K	0.0%	+35.2%	0.004%
10/23/2024	Allworth Financial LP	900	$29K	0.0%	+800.0%	0.001%
10/23/2024	Values First Advisors Inc.	2,345	$74K	0.0%	N/A	0.003%
10/11/2024	Creative Planning	8,677	$0.28M	0.0%	N/A	0.010%
10/3/2024	SG Americas Securities LLC	3,397	$0.11M	0.0%	-71.2%	0.004%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	14,500	$0.51M	0.0%	-70.4%	0.019%
8/16/2024	Algert Global LLC	12,676	$0.45M	0.0%	-65.6%	0.017%
8/16/2024	Driehaus Capital Management LLC	437,123	$15.35M	0.1%	-1.1%	0.578%
8/15/2024	Scientech Research LLC	27,708	$0.97M	0.2%	+362.3%	0.037%
8/15/2024	The Manufacturers Life Insurance Company	104,784	$3.68M	0.0%	-6.4%	0.138%
8/15/2024	Millennium Management LLC	258,606	$9.08M	0.0%	+87.1%	0.342%
8/15/2024	D. E. Shaw & Co. Inc.	884,538	$31.06M	0.0%	+34.4%	1.169%
8/15/2024	Deerfield Management Company L.P. Series C	2,097,113	$73.63M	1.2%	-20.3%	2.771%
8/15/2024	AQR Capital Management LLC	15,632	$0.55M	0.0%	-7.5%	0.021%
8/14/2024	Squarepoint Ops LLC	100,502	$3.53M	0.0%	+127.1%	0.133%
8/14/2024	Fred Alger Management LLC	11,994	$0.42M	0.0%	-29.0%	0.016%
8/14/2024	Marshall Wace LLP	98,811	$3.47M	0.0%	-10.5%	0.131%
8/14/2024	Samlyn Capital LLC	611,820	$21.48M	0.4%	+27.1%	0.808%
8/14/2024	Logos Global Management LP	1,700,000	$59.69M	4.8%	+13.3%	2.246%
8/14/2024	Magnetar Financial LLC	45,550	$1.60M	0.0%	N/A	0.060%
8/14/2024	HighVista Strategies LLC	40,856	$1.43M	0.5%	-58.9%	0.054%
8/14/2024	ProShare Advisors LLC	13,920	$0.49M	0.0%	-18.3%	0.018%
8/14/2024	Profund Advisors LLC	22,823	$0.80M	0.0%	-28.5%	0.030%
8/13/2024	Ensign Peak Advisors Inc	483,714	$16.98M	0.0%	-1.0%	0.639%
8/12/2024	Hsbc Holdings PLC	15,269	$0.53M	0.0%	+80.1%	0.020%
8/12/2024	E Fund Management Co. Ltd.	7,298	$0.26M	0.0%	-23.3%	0.010%
8/10/2024	Sofinnova Investments Inc.	1,151,528	$40.43M	2.1%	+47.3%	1.521%
8/9/2024	Renaissance Technologies LLC	109,325	$3.84M	0.0%	N/A	0.144%
8/9/2024	Dimensional Fund Advisors LP	1,094,872	$38.44M	0.0%	-19.8%	1.447%
8/8/2024	Envestnet Asset Management Inc.	104,553	$3.67M	0.0%	+24.5%	0.138%
8/8/2024	Oppenheimer Asset Management Inc.	12,213	$0.43M	0.0%	+16.7%	0.016%
8/8/2024	Federated Hermes Inc.	4,855,790	$170.49M	0.4%	0.0%	6.416%
8/8/2024	Nicholas Investment Partners LP	71,036	$2.49M	0.3%	-54.4%	0.094%
8/8/2024	American Century Companies Inc.	8,541	$0.30M	0.0%	-14.0%	0.011%
8/8/2024	State of New Jersey Common Pension Fund D	51,792	$1.82M	0.0%	-14.2%	0.068%
8/7/2024	Daiwa Securities Group Inc.	1,948	$68K	0.0%	+637.9%	0.003%
8/6/2024	Quest Partners LLC	1,178	$41K	0.0%	N/A	0.002%
8/6/2024	Candriam S.C.A.	629,019	$22.08M	0.1%	-0.2%	0.831%
8/5/2024	Arizona State Retirement System	17,742	$0.62M	0.0%	+14.3%	0.023%
8/5/2024	Victory Capital Management Inc.	316,105	$11.10M	0.0%	+10.3%	0.418%
8/3/2024	TD Asset Management Inc	116,690	$4.10M	0.0%	-35.8%	0.154%
8/1/2024	Fiera Capital Corp	1,335,410	$46.89M	0.1%	+22.6%	1.764%
8/1/2024	Rhumbline Advisers	105,797	$3.72M	0.0%	+9.7%	0.140%
7/29/2024	Principal Financial Group Inc.	12,688	$0.45M	0.0%	-16.9%	0.017%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	16,449	$0.58M	0.0%	-9.7%	0.022%
7/26/2024	Legato Capital Management LLC	9,104	$0.32M	0.0%	-38.5%	0.012%
7/26/2024	Bank of New York Mellon Corp	316,492	$11.11M	0.0%	+43.0%	0.418%
7/20/2024	China Universal Asset Management Co. Ltd.	8,893	$0.31M	0.0%	-38.0%	0.012%
7/20/2024	Nisa Investment Advisors LLC	3,340	$0.12M	0.0%	+38.4%	0.004%
7/12/2024	SG Americas Securities LLC	11,775	$0.41M	0.0%	+411.3%	0.016%
5/28/2024	Boston Partners	13,391	$0.59M	0.0%	N/A	0.018%

Data available starting January 2016

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 1/2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung, bladder, gastric, and esophageal cancers; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; GSK101, a Pol Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other homologous recombination, and HRD mutations; and Werner Helicase inhibitors for tumors with high microsatellite instability. It offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Novartis International Pharmaceuticals Ltd., Amgen Inc., Gilead Sciences, Inc., Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Today's Range

Now: $25.61

$24.51

$26.49

50 Day Range

MA: $28.28

$24.79

$31.98

52 Week Range

Now: $25.61

$24.48

$47.74

Volume

1,937,098 shs

Average Volume

870,979 shs

Market Capitalization

$2.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of IDEAYA Biosciences?: IDEAYA Biosciences' top insider investors include:
Yujiro S Hata (CEO)
Jason Throne (Insider)
Briseno Andres Ruiz (Insider)
Paul A Stone (CFO)
Michael Anthony White (Insider)
Learn More about top insider investors at IDEAYA Biosciences.
Who are the major institutional investors of IDEAYA Biosciences?: IDEAYA Biosciences' top institutional shareholders include:
FMR LLC — 14.62%
Janus Henderson Group PLC — 5.97%
State Street Corp — 3.84%
Geode Capital Management LLC — 2.25%
RA Capital Management L.P. — 1.56%
Fiera Capital Corp — 1.53%
Learn More about top institutional investors of IDEAYA Biosciences stock.
Which institutional investors are selling IDEAYA Biosciences stock?: Within the last quarter, IDYA stock was sold by these institutional investors:
Holocene Advisors LP
Wellington Management Group LLP
Redmile Group LLC
Jane Street Group LLC
BNP Paribas Financial Markets
Fiera Capital Corp
Connor Clark & Lunn Investment Management Ltd.
SG Americas Securities LLC
Within the last year, company insiders that have sold IDEAYA Biosciences company stock include:
Yujiro S Hata (CEO)
Jason Throne (Insider)
Briseno Andres Ruiz (Insider)
Learn More investors selling IDEAYA Biosciences stock.
Which institutional investors are buying IDEAYA Biosciences stock?: In the last quarter, IDYA stock was acquired by institutional investors including:
FMR LLC
RA Capital Management L.P.
Janus Henderson Group PLC
Jennison Associates LLC
State Street Corp
abrdn plc
RTW Investments LP
Fisher Asset Management LLC